Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics (EXPRESA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00721097|
Recruitment Status : Terminated (Number of included patients is sufficient.)
First Posted : July 23, 2008
Last Update Posted : September 30, 2013
|Condition or disease||Intervention/treatment|
|Asthma Chronic Inflammatory Diseases||Other: spirometry, and blood taken|
|Study Type :||Observational|
|Actual Enrollment :||40 participants|
|Official Title:||Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics|
|Study Start Date :||June 2008|
|Primary Completion Date :||May 2011|
|Study Completion Date :||May 2011|
Other: spirometry, and blood taken
- Number of predictive factors for exacerbation outcome in severe asthmatics.
- Rate of predictive factors identified in the study, in order to prevent exacerbations.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00721097
|nantes University Hospital|
|Nantes, France, 44093|
|Principal Investigator:||Antoine MAGNAN, MD||CHU de Nantes|